The development of cancer agents is a rigorous process that involves multiple stages of research and clinical trials. Initially, a potential agent is identified through laboratory research and preclinical studies. If these studies show promise, the agent moves to clinical trials, which are conducted in phases to assess its safety, efficacy, and optimal dosing.
